322 related articles for article (PubMed ID: 29104036)
1. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.
Zhang L; Chen C; Zhou N; Fu Y; Cheng X
Clin Chim Acta; 2019 Feb; 489():183-188. PubMed ID: 29104036
[TBL] [Abstract][Full Text] [Related]
2. Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases.
Li X; Liao M; Shen R; Zhang L; Hu H; Wu J; Wang X; Qu H; Guo S; Long M; Zheng H
Mediators Inflamm; 2018; 2018():7375294. PubMed ID: 30524197
[TBL] [Abstract][Full Text] [Related]
3. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.
Wang Y; Qu H; Xiong X; Qiu Y; Liao Y; Chen Y; Zheng Y; Zheng H
Mediators Inflamm; 2018; 2018():9471583. PubMed ID: 29743813
[TBL] [Abstract][Full Text] [Related]
4. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome.
Alan M; Gurlek B; Yilmaz A; Aksit M; Aslanipour B; Gulhan I; Mehmet C; Taner CE
Gynecol Endocrinol; 2019 Mar; 35(3):220-223. PubMed ID: 30325247
[TBL] [Abstract][Full Text] [Related]
5. Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity.
Wang M; Yin C; Wang L; Liu Y; Li H; Li M; Yi X; Xiao Y
Ann Nutr Metab; 2019; 75(4):205-212. PubMed ID: 31775140
[TBL] [Abstract][Full Text] [Related]
6. Decreased Circulating Levels of Asprosin in Obese Children.
Long W; Xie X; Du C; Zhao Y; Zhang C; Zhan D; Li Z; Ning Q; Luo X
Horm Res Paediatr; 2019; 91(4):271-277. PubMed ID: 31212299
[TBL] [Abstract][Full Text] [Related]
7. Serum asprosin levels and bariatric surgery outcomes in obese adults.
Wang CY; Lin TA; Liu KH; Liao CH; Liu YY; Wu VC; Wen MS; Yeh TS
Int J Obes (Lond); 2019 May; 43(5):1019-1025. PubMed ID: 30459402
[TBL] [Abstract][Full Text] [Related]
8. Serum concentration of asprosin in new-onset type 2 diabetes.
Naiemian S; Naeemipour M; Zarei M; Lari Najafi M; Gohari A; Behroozikhah MR; Heydari H; Miri M
Diabetol Metab Syndr; 2020; 12():65. PubMed ID: 32714446
[TBL] [Abstract][Full Text] [Related]
9. Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value.
Zhong M; Tian X; Sun Q; Li L; Lu Y; Feng Z; Gao Y; Li S
BMC Endocr Disord; 2023 Mar; 23(1):61. PubMed ID: 36915073
[TBL] [Abstract][Full Text] [Related]
10. Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus.
Zhang X; Jiang H; Ma X; Wu H
J Diabetes Investig; 2020 Mar; 11(2):349-355. PubMed ID: 31529619
[TBL] [Abstract][Full Text] [Related]
11. Asprosin, a Fasting-Induced Glucogenic Protein Hormone.
Romere C; Duerrschmid C; Bournat J; Constable P; Jain M; Xia F; Saha PK; Del Solar M; Zhu B; York B; Sarkar P; Rendon DA; Gaber MW; LeMaire SA; Coselli JS; Milewicz DM; Sutton VR; Butte NF; Moore DD; Chopra AR
Cell; 2016 Apr; 165(3):566-79. PubMed ID: 27087445
[TBL] [Abstract][Full Text] [Related]
12. Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes.
Groener JB; Valkanou A; Kender Z; Pfeiffenberger J; Kihm L; Fleming T; Nawroth PP; Kopf S
PLoS One; 2019; 14(9):e0222771. PubMed ID: 31536600
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
[TBL] [Abstract][Full Text] [Related]
14. Effects of GLP-1 receptor agonists on asprosin levels in normal weight or overweight/obesity patients with type 2 diabetes mellitus.
Dai C; Zhu W
Medicine (Baltimore); 2022 Oct; 101(43):e31334. PubMed ID: 36316938
[TBL] [Abstract][Full Text] [Related]
15. The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients.
Chang CL; Huang SY; Hsu YC; Chin TH; Soong YK
Sci Rep; 2019 Apr; 9(1):6447. PubMed ID: 31015585
[TBL] [Abstract][Full Text] [Related]
16. Circulating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances.
Nedeva IS; Assyov Y; Karamfilova V; Vodenicharov V; Gerganova A; Hristova J; Kamenov Z
Horm Metab Res; 2023 Apr; 55(4):284-289. PubMed ID: 36773601
[TBL] [Abstract][Full Text] [Related]
17. Asprosin serum levels and glucose homeostasis in children with obesity.
Corica D; Aversa T; Currò M; Tropeano A; Pepe G; Alibrandi A; Ientile R; Wasniewska M
Cytokine; 2021 Jun; 142():155477. PubMed ID: 33662891
[TBL] [Abstract][Full Text] [Related]
18. Circulating Betatrophin Correlates with Triglycerides and Postprandial Glucose among Different Glucose Tolerance Statuses--A Case-Control Study.
Gao T; Jin K; Chen P; Jin H; Yang L; Xie X; Yang M; Hu C; Yu X
PLoS One; 2015; 10(8):e0133640. PubMed ID: 26247824
[TBL] [Abstract][Full Text] [Related]
19. Maternal exposure to air pollution and umbilical asprosin concentration, a novel insulin-resistant marker.
Hosseini ZS; Heydari-Zarnagh H; Lari Najafi M; Behmanesh M; Miri M
Chemosphere; 2021 Apr; 268():129228. PubMed ID: 33352518
[TBL] [Abstract][Full Text] [Related]
20. Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus.
Diao H; Li X; Xu Y; Xing X; Pang S
J Diabetes Complications; 2023 Nov; 37(11):108614. PubMed ID: 37769508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
